You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


New pricing models could improve access to innovative cancer drugs

A consensus panel has concluded that the NHS could improve patient access to new cancer drugs by varying the price it pays for different medicines depending on what disease they are used to treat.